Home › NDC Lookup › Ingredients › Polyvinyl Alcohol, Povidone › 83324-0189-14
Quality Choice Artificial Tears Lubricant Eye Drops Polyvinyl alcohol, Povidone .5 g/100mL; .6 g/100mL Solution/ Drops — NDC 83324-0189-14 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Quality Choice Artificial Tears Lubricant Eye Drops Polyvinyl alcohol, Povidone .5 g/100mL; .6 g/100mL Solution/ Drops — NDC 83324-189-14 (Billing 83324-0189-14)

by Chain Drug Marketing Association, Inc. · 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER

This is a package of Quality Choice Artificial Tears Lubricant Eye Drops Polyvinyl alcohol, Povidone .5 g/100mL; .6 g/100mL Solution/ Drops from Chain Drug Marketing Association, Inc., marketed since Aug 2024 and currently FDA-listed; retail pharmacies pay about $0.1133 per mL (NADAC). It is this product's only package size.

NDC 83324-0189-14
🏷️ FDA NDC (as labeled) 83324-189-14 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 83324-189-14 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
83324 labeler · 189 product · 14 package
Package marketed since
Aug 11, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0635515992238
FDA record last changed
Jul 24, 2026
🚨
Active recall for this product.
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0416-2026
Lots / codes: Lot: a) AT24D01, Exp.: 04/30/26; AT24E01, Exp.: 05/31/26; AT24G01, Exp.: 07/31/26; b) AT24D01, Exp.: 04/30/26; AT24E01, AT24E02, Exp.: 05/31/26; AT24G01, Exp.: 07/31/26; c) AT24D01, Exp.: 04/30/26; AT24E01, Exp.: 05/31/26; AT24G01, Exp.: 07/31/26; d) AT24D01, Exp.: 04/30/26; AT24E01, AT24E02, Exp.: 05/31/26; AT24G01, Exp.: 07/31/26; e) AT24E01, Exp.: 05/31/… · reported Apr 8, 2026
Check your lot/expiration against the official notice — look up the recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 83324-189-14
Product NDC 83324-189
11-digit billing NDC 83324018914
NCPDP billing unit ML — per mL (volume)
RxCUI 598050
UNII 532B59J990, FZ989GH94E
UPC 0635515992238
Application # M018
SPL Set ID 1f669655-4bc7-0175-e063-6294a90a305a
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-08-11
Route OPHTHALMIC
Dosage form SOLUTION/ DROPS
Substance POLYVINYL ALCOHOL; POVIDONE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86209902502010
GCN Seq No 051850
GCN 19246
HICL code 003500
Ingredient (HICL) Polyvinyl Alcohol/Povidone
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6T
Therapeutic class — specific (HIC3) Artificial Tears
AHFS code 52:92.00.00
AHFS class Eent Drugs, Miscellaneous
FDB label name QC ARTIFICIAL TEARS DROPS
FDB brand name Artificial Tears
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 051850
  • GCN: 19246
  • GPI-14 (Medi-Span): 86209902502010
  • HICL (First Databank): 003500
  • AHFS class code: 52:92.00.00
  • RxCUI (RxNorm): 598050
Why two NDCs? The FDA registers this code as 83324-189-14 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 83324-0189-14. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name QC ARTIFICIAL TEARS DROPS Ingredient Polyvinyl Alcohol/Povidone
🧪 What is this product?

Quality Choice Artificial Tears Lubricant Eye Drops is an over-the-counter eye drop solution containing polyvinyl alcohol and povidone. These ingredients are lubricants typically used to relieve dryness and irritation of the eye surface. The drops function by coating the eye and helping to retain moisture, making them commonly used by people experiencing dry eyes from environmental conditions, prolonged screen time, or other causes.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.113 $1.70 / 15 ml
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.144 $0.113
▼ Down 6% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
83324-0189-14 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER 2024-08-11 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops .5 g/100mL; .6 g/100mL 24385-0006-05 AmerisourceBergen 1 bottle $0.113 — Availability likely —
Leader Artificial Tears 15 mL .5 g/100mL; .6 g/100mL 70000-0011-01 Cardinal 1 bottle $0.113 — Availability likely —
Quality Choice Artificial Tears Lubricant Eye Drops .5 g/100mL; .6 g/100mLthis 83324-0189-14 Chain 1 bottle $0.113 — Availability likely —
Walgreens Soothing Eye Relief Lubricant Eye Drops .5 g/100mL; .6 g/100mL 00363-0796-01 Walgreens 1 bottle — — FDA listed —
Topcare Health Artificial Tears .5 g/100mL; .6 g/100mL 36800-0972-01 Topco 1 bottle — — FDA listed —
Meijer Artificial Tears .6 g/100mL; .5 g/100mL 41250-0819-01 Meijer 1 bottle — — FDA listed —
Good Sense Artificial Tears .5 g/100mL; .6 g/100mL 50804-0110-01 Geiss, 1 bottle — — FDA listed —
Family Wellness Artificial Tears .6 g/100mL; .5 g/100mL 55319-0908-01 Family 1 bottle — — FDA listed —
Artificial Tears 6 mg/mL; 5 mg/mL 55651-0008-01 KC 1 bottle — — FDA listed —
Publix Artificial Tears Eye Drops 500 mg/100mL; 600 mg/100mL 56062-0666-01 Publix 1 bottle — — FDA listed —
Kroger Eye Drops Artificial Tears .6 g/100mL; .5 g/100mL 59450-0814-01 The 1 bottle — — FDA listed —
Stye 5 mg/mL; 6 mg/mL 63029-0324-15 Medtech 1 bottle — — FDA listed —
Goodsense Artificial Tears 5 mg/mL; 6 mg/mL 63187-0298-15 Proficient 1 bottle — — FDA listed —
GoodSense Artifical Tears .05 g/mL; .06 g/mL 63187-0893-15 Proficient 1 bottle — — FDA listed —
Best Choice Artificial Tears .5 g/100mL; .6 g/100mL 63941-0015-01 Best 1 bottle — — FDA listed —
Artificial Tears Lubricant Eye 5 mg/mL; 6 mg/mL 67172-0181-01 Prestige 1 bottle — — Discontinued —
Clear Eyes Natural Tears 5 mg/mL; 6 mg/mL 67172-0557-02 Prestige 1 bottle — — FDA listed —
Artificial Tears .5 g/100mL; .6 g/100mL 68071-4914-05 NuCare 15 ml — — FDA listed —
Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops .5 g/100mL; .6 g/100mL 71205-0134-15 Proficient 15 ml — — FDA listed —
CareOne Artificial Tears Eye Drops 15mL .5 g/100mL; .6 g/100mL 72476-0038-01 Retail 1 bottle — — FDA listed —
Equate Artificial Tears .6 g/100mL; .5 g/100mL 79903-0157-05 Walmart, 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Aug 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII F5UM2KM3W7
    Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 660YQ98I10
    Potassium chloride is a mineral salt used in medicines as a buffer and to help maintain the proper pH balance and stability of the formulation during storage and use.
  • UNII 8MDF5V39QO
    A white powder form of baking soda that acts as a buffer and pH regulator in medicines. It helps maintain the right acid-base balance and may aid tablet disintegration.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII GR686LBA74
    Sodium phosphate, dibasic is a salt derived from phosphoric acid. It acts as a buffer to help maintain the medicine's pH balance and may serve as a binder or filler in tablets and capsules.
  • UNII 3980JIH2SW
    A salt form of phosphoric acid that acts as a buffer and pH adjuster in medicines. It helps keep the product at the correct acidity level for stability and effectiveness.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzalkonium chloride, dextrose, edetate disodium, potassium chloride, purified water, sodium bicarbonate, sodium chloride, sodium citrate, sodium phosphate dibasic, and sodium phosphate monobasic

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerChain Drug Marketing Association, Inc.
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code83324
First marketedAug 2024
Product typeHuman Otc Drug
Portfolio122 products on file

More NDCs from Chain Drug Marketing Association, Inc. labeler code 83324

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 36 words ▾

Uses for use as a protectant against further irritation or to relieve dryness of the eye for the temporary relief of discomfort due to minor irritations of the eye, or to exposure to wind or sun

⏱️ Dosage and Administration 12 words ▾

Directions Instill 1 or 2 drops in the affected eye(s) as needed.

⚠️ Warnings 100 words ▾

Warnings For external use only Do not use this product if solution changes color or becomes cloudy When using this product remove contact lens before using to avoid contamination, do not touch tip of container to any surface replace cap after using. Keep container tightly closed Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye or if the condition worsens or persists for more than 72 hours Keep out of the reach of children. If accidentally swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

🧪 Active Ingredient 7 words ▾

Active Ingredients Polyvinyl alcohol 0.5% Povidone 0.6%

🧪 Inactive Ingredients 24 words ▾

Inactive ingredients benzalkonium chloride, dextrose, edetate disodium, potassium chloride, purified water, sodium bicarbonate, sodium chloride, sodium citrate, sodium phosphate dibasic, and sodium phosphate monobasic

🎯 Purpose 3 words ▾

Purpose Lubricant Lubricant

📄 Do Not Use 12 words ▾

Do not use this product if solution changes color or becomes cloudy

📄 When Using This Product 29 words ▾

When using this product remove contact lens before using to avoid contamination, do not touch tip of container to any surface replace cap after using. Keep container tightly closed

📄 Stop Use and Ask a Doctor If 33 words ▾

Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye or if the condition worsens or persists for more than 72 hours

📄 Keep Out of Reach of Children 21 words ▾

Keep out of the reach of children. If accidentally swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

📄 Other Information 6 words ▾

Other information Store at 15°-30°C (59°-86°F)

📄 Package Label / Principal Display Panel 16 words ▾

Quality Choice Artificial Tears Lubricant Eye Drops 15mL Quality Choice Artificial Tears Lubricant Eye Drops 15mL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Quality Choice Artificial Tears Lubricant Eye Drops (this brand).

Top reported reactions

Fungal Sepsis2
Anticholinergic Syndrome1
Product Taste Abnormal1
Recalled Product Administered1
Throat Irritation1

Reporter sex

3 reports
Female · 100%

Serious outcomes

Hospitalization3
Life-threatening2
Death2
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 2 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 83324-0188-12 · Chain 83324-0190-14 · Quality →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.